α-Melanocyte-related tripeptide, Lys-D-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation

evidence for involvement of an interleukin-1β193-195 receptor antagonism in the alveolar epithelium

John J..E. Haddad, Ryszard Lauterbach, Nayef E. Saadé, Bared Safieh-Garabedian, Stephen C. Land

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The potential anti-inflammatory role of α-melanocyte-stimulating hormone (α-MSH)-related tripeptide, lysine11-D-proline-valine13 (KDPV), an analogue of interleukin (IL)-1β193-195 and an antagonist- of IL-1β/prostaglandin E2, is not well characterized in the alveolar epithelium. In a model of foetal alveolar type II epithelial cells in vitro, we showed that lipopolysaccharide endotoxin (LPS) differentially, but selectively, induced the nuclear subunit composition of nuclear factor κB1 (NF-κB1) (p50), Re1A (p65) and c-Re1 (p75), in parallel to up-regulating the DNA-binding-activity (supershift indicating the presence of the p50-p65 complex). LPS accelerated the degradation of inhibitory κB-α (IκB-α), accompanied by enhancing its phosphorylation in the cytosolic compartment but not in the nucleus. KDPV suppressed, in a dose-dependent manner, the nuclear localization of p50, p65 and p75, an effect that led to the subsequent inhibition of NF-κB activation. Interleukin-1 receptor antagonist (IL-1ra) decreased the nuclear abundance of p50, p65 and p75, and subsequently depressed the DNA-binding activity induced by. LPS. Analysis of the mechanism involved in the KDPV- and IL-1ra-mediated inhibition of NF-κB nuclear localization revealed a reversal in IκB-α phosphorylation and degradation, followed by cytosolic accumulation. LPS induced endogenous IL-1β biosynthesis in a time-dependent manner; the administration of exogenous recombinant human interleukin 1 (rhIL-1) resulted in a dose-dependent activation of NF-κB. KDPV and IL-1ra abrogated the effect of rhIL-1. Pretreatment with the non-steroidal anti-inflammatory drug (NSAID) indomethacin, an inhibitor of cyclo-oxygenase, blocked the LPS-induced activation of NF-κB. These results indicate the involvement of prostanoid-dependent (NSAID-sensitive) and IL:1-dependent (IL-1ra-sensitive) mechanisms mediating LPS-induced NF-κB translocation and activation, a pathway that is regulated, in part, by a negative feedback mechanism transduced through IκB-α, the major cytosolic inhibitor of NF-κB.

Original languageEnglish
Pages (from-to)29-38
Number of pages10
JournalBiochemical Journal
Volume355
Issue number1
DOIs
Publication statusPublished - 1 Apr 2001

Fingerprint

prolylvaline
Interleukins
Melanocytes
Endotoxins
Lipopolysaccharides
Interleukin-1
Epithelium
Chemical activation
Phosphorylation
Anti-Inflammatory Agents
Melanocyte-Stimulating Hormones
Alveolar Epithelial Cells
Degradation
Interleukin-1 Receptors
Cyclooxygenase Inhibitors
DNA
Biosynthesis
Dinoprostone
Proline
Indomethacin

Keywords

  • Cytokine
  • Inhibitory κB-α
  • Pathophysiology
  • Prostaglandin
  • α-melanocyte-stimulating hormone

Cite this

@article{4f0412adc8f84a02aa91c1005dbb700d,
title = "α-Melanocyte-related tripeptide, Lys-D-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation: evidence for involvement of an interleukin-1β193-195 receptor antagonism in the alveolar epithelium",
abstract = "The potential anti-inflammatory role of α-melanocyte-stimulating hormone (α-MSH)-related tripeptide, lysine11-D-proline-valine13 (KDPV), an analogue of interleukin (IL)-1β193-195 and an antagonist- of IL-1β/prostaglandin E2, is not well characterized in the alveolar epithelium. In a model of foetal alveolar type II epithelial cells in vitro, we showed that lipopolysaccharide endotoxin (LPS) differentially, but selectively, induced the nuclear subunit composition of nuclear factor κB1 (NF-κB1) (p50), Re1A (p65) and c-Re1 (p75), in parallel to up-regulating the DNA-binding-activity (supershift indicating the presence of the p50-p65 complex). LPS accelerated the degradation of inhibitory κB-α (IκB-α), accompanied by enhancing its phosphorylation in the cytosolic compartment but not in the nucleus. KDPV suppressed, in a dose-dependent manner, the nuclear localization of p50, p65 and p75, an effect that led to the subsequent inhibition of NF-κB activation. Interleukin-1 receptor antagonist (IL-1ra) decreased the nuclear abundance of p50, p65 and p75, and subsequently depressed the DNA-binding activity induced by. LPS. Analysis of the mechanism involved in the KDPV- and IL-1ra-mediated inhibition of NF-κB nuclear localization revealed a reversal in IκB-α phosphorylation and degradation, followed by cytosolic accumulation. LPS induced endogenous IL-1β biosynthesis in a time-dependent manner; the administration of exogenous recombinant human interleukin 1 (rhIL-1) resulted in a dose-dependent activation of NF-κB. KDPV and IL-1ra abrogated the effect of rhIL-1. Pretreatment with the non-steroidal anti-inflammatory drug (NSAID) indomethacin, an inhibitor of cyclo-oxygenase, blocked the LPS-induced activation of NF-κB. These results indicate the involvement of prostanoid-dependent (NSAID-sensitive) and IL:1-dependent (IL-1ra-sensitive) mechanisms mediating LPS-induced NF-κB translocation and activation, a pathway that is regulated, in part, by a negative feedback mechanism transduced through IκB-α, the major cytosolic inhibitor of NF-κB.",
keywords = "Cytokine, Inhibitory κB-α, Pathophysiology, Prostaglandin, α-melanocyte-stimulating hormone",
author = "Haddad, {John J..E.} and Ryszard Lauterbach and Saad{\'e}, {Nayef E.} and Bared Safieh-Garabedian and Land, {Stephen C.}",
year = "2001",
month = "4",
day = "1",
doi = "10.1042/bj3550029",
language = "English",
volume = "355",
pages = "29--38",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press",
number = "1",

}

α-Melanocyte-related tripeptide, Lys-D-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation : evidence for involvement of an interleukin-1β193-195 receptor antagonism in the alveolar epithelium. / Haddad, John J..E.; Lauterbach, Ryszard; Saadé, Nayef E.; Safieh-Garabedian, Bared; Land, Stephen C.

In: Biochemical Journal, Vol. 355, No. 1, 01.04.2001, p. 29-38.

Research output: Contribution to journalArticle

TY - JOUR

T1 - α-Melanocyte-related tripeptide, Lys-D-Pro-Val, ameliorates endotoxin-induced nuclear factor κB translocation and activation

T2 - evidence for involvement of an interleukin-1β193-195 receptor antagonism in the alveolar epithelium

AU - Haddad, John J..E.

AU - Lauterbach, Ryszard

AU - Saadé, Nayef E.

AU - Safieh-Garabedian, Bared

AU - Land, Stephen C.

PY - 2001/4/1

Y1 - 2001/4/1

N2 - The potential anti-inflammatory role of α-melanocyte-stimulating hormone (α-MSH)-related tripeptide, lysine11-D-proline-valine13 (KDPV), an analogue of interleukin (IL)-1β193-195 and an antagonist- of IL-1β/prostaglandin E2, is not well characterized in the alveolar epithelium. In a model of foetal alveolar type II epithelial cells in vitro, we showed that lipopolysaccharide endotoxin (LPS) differentially, but selectively, induced the nuclear subunit composition of nuclear factor κB1 (NF-κB1) (p50), Re1A (p65) and c-Re1 (p75), in parallel to up-regulating the DNA-binding-activity (supershift indicating the presence of the p50-p65 complex). LPS accelerated the degradation of inhibitory κB-α (IκB-α), accompanied by enhancing its phosphorylation in the cytosolic compartment but not in the nucleus. KDPV suppressed, in a dose-dependent manner, the nuclear localization of p50, p65 and p75, an effect that led to the subsequent inhibition of NF-κB activation. Interleukin-1 receptor antagonist (IL-1ra) decreased the nuclear abundance of p50, p65 and p75, and subsequently depressed the DNA-binding activity induced by. LPS. Analysis of the mechanism involved in the KDPV- and IL-1ra-mediated inhibition of NF-κB nuclear localization revealed a reversal in IκB-α phosphorylation and degradation, followed by cytosolic accumulation. LPS induced endogenous IL-1β biosynthesis in a time-dependent manner; the administration of exogenous recombinant human interleukin 1 (rhIL-1) resulted in a dose-dependent activation of NF-κB. KDPV and IL-1ra abrogated the effect of rhIL-1. Pretreatment with the non-steroidal anti-inflammatory drug (NSAID) indomethacin, an inhibitor of cyclo-oxygenase, blocked the LPS-induced activation of NF-κB. These results indicate the involvement of prostanoid-dependent (NSAID-sensitive) and IL:1-dependent (IL-1ra-sensitive) mechanisms mediating LPS-induced NF-κB translocation and activation, a pathway that is regulated, in part, by a negative feedback mechanism transduced through IκB-α, the major cytosolic inhibitor of NF-κB.

AB - The potential anti-inflammatory role of α-melanocyte-stimulating hormone (α-MSH)-related tripeptide, lysine11-D-proline-valine13 (KDPV), an analogue of interleukin (IL)-1β193-195 and an antagonist- of IL-1β/prostaglandin E2, is not well characterized in the alveolar epithelium. In a model of foetal alveolar type II epithelial cells in vitro, we showed that lipopolysaccharide endotoxin (LPS) differentially, but selectively, induced the nuclear subunit composition of nuclear factor κB1 (NF-κB1) (p50), Re1A (p65) and c-Re1 (p75), in parallel to up-regulating the DNA-binding-activity (supershift indicating the presence of the p50-p65 complex). LPS accelerated the degradation of inhibitory κB-α (IκB-α), accompanied by enhancing its phosphorylation in the cytosolic compartment but not in the nucleus. KDPV suppressed, in a dose-dependent manner, the nuclear localization of p50, p65 and p75, an effect that led to the subsequent inhibition of NF-κB activation. Interleukin-1 receptor antagonist (IL-1ra) decreased the nuclear abundance of p50, p65 and p75, and subsequently depressed the DNA-binding activity induced by. LPS. Analysis of the mechanism involved in the KDPV- and IL-1ra-mediated inhibition of NF-κB nuclear localization revealed a reversal in IκB-α phosphorylation and degradation, followed by cytosolic accumulation. LPS induced endogenous IL-1β biosynthesis in a time-dependent manner; the administration of exogenous recombinant human interleukin 1 (rhIL-1) resulted in a dose-dependent activation of NF-κB. KDPV and IL-1ra abrogated the effect of rhIL-1. Pretreatment with the non-steroidal anti-inflammatory drug (NSAID) indomethacin, an inhibitor of cyclo-oxygenase, blocked the LPS-induced activation of NF-κB. These results indicate the involvement of prostanoid-dependent (NSAID-sensitive) and IL:1-dependent (IL-1ra-sensitive) mechanisms mediating LPS-induced NF-κB translocation and activation, a pathway that is regulated, in part, by a negative feedback mechanism transduced through IκB-α, the major cytosolic inhibitor of NF-κB.

KW - Cytokine

KW - Inhibitory κB-α

KW - Pathophysiology

KW - Prostaglandin

KW - α-melanocyte-stimulating hormone

UR - http://www.scopus.com/inward/record.url?scp=0035310404&partnerID=8YFLogxK

U2 - 10.1042/bj3550029

DO - 10.1042/bj3550029

M3 - Article

VL - 355

SP - 29

EP - 38

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -